Global Bovine Blood Plasma Derivatives Market: Snapshot
Bovine blood plasma derivatives are exclusive in a way when it comes to delivering palatability, something that cannot be achieved via other alternatives such as plant extracted proteins and other synthetic nutrient elements. Bovine immunoglobulin G (IgG) is one the most common commercially available bovine derived protein fractions, while some of the others are thrombin and fibrinogen. Although, currently the bovine blood plasma derivatives market is gaining traction from its expanding usage across various industries including pharmaceutical, medical diagnostics, and cosmetics, the food industry and cell culture media continues to provide for the maximum demand. According to this fresh business intelligence study, the demand in the global bovine blood plasma derivatives market will increment at a notable CAGR of 5.8% during the forecast period of 2017 to 2025. The analysts of the report have evaluated that the opportunities in the bovine blood plasma derivatives market, globally, constituted for a revenue of US$1,338.9 mn in 2016 and US$1404.2 mn in 2017, and the valuation is estimated to swell up to US$2,196.8 mn by the end of 2025.
Growing usage of blood plasma products in the food industry, which is experiencing an extended demand for food products with nutritious values, is the primary driver of the bovine blood plasma derivatives market. Additionally, advancements in the technology of blood collection and processing as well as recent improvements to the supply chain and distribution network by the vendors are some of the other key factors driving the demand in the global bovine blood plasma derivatives market.
Demand for Thrombin Derivative Segment to Remain Prominent Until 2025
The market for bovine blood plasma derivatives has been broadly segmented into immunoglobulin, fibrinogen, serum albumin, fetal bovine serum, thrombin, transferrin, new born calf serum, and others including BGG. In 2017, the thrombin segment provided for the maximum demand, which was a result of its increasing usage during surgeries and diagnostic purposes. R&D applications of thrombin includes research activities such as in vitro study, coagulation research, protein structure analysis, medical research, and biochemical research. Bovine serum albumin is expected to maintain its position as the second leading segment of the bovine blood plasma derivatives market until 2025. Bovine serum albumin has applications in the food industry, drug formulation, and as a component of media for cell culture. Bovine derived albumins are used in production of several vaccine as well as in cell culture related work, including cryopreservation and effective washing of cells. Bovine serum albumin (BSA) is used as standard for protein concentrations (Bradford protein assay) in cell culture protocols as well as small molecule carrier.
Application-wise, the bovine blood plasma derivatives market has been bifurcated into pharmaceutical industry, diagnostic industry, cell culture or biotechnology, research and development, food industry, cosmetic industry, others including nutrition supplements. In 2015, the cell culture or biotechnology and the food industry collectively provided for a demand share of 42.2%, and both are anticipated to remain as the most profitable application segment until 2025.
North America to Remain the Most Lucrative Region
Geographically, North America and Asia Pacific are the two more lucrative regions. While the analysts of the report have projected the North America bovine blood plasma derivatives market to prosper at a CAGR of 6.7% during the forecast period of 2017 to 2025, the Asia Pacific bovine blood plasma derivatives market is estimated to be worth US$493.9 mn by 2025. These two regions are anticipated to constitute for more than 60% of the total opportunities and revenue in this market.
Some of the key players who operate at the global level in the bovine blood plasma derivatives market are Sigma-Aldrich Co. (Merck KGaA), LAMPIRE Biological Laboratories, Inc., Proliant Inc., Rocky Mountain Biologicals Inc., Bovogen Biologicals Pty Ltd., Thermo Fisher Scientific, Inc., Kraeber & Co GmbH, Auckland BioSciences Ltd., and Lake Immunogenics, Inc.
Global Bovine Blood Plasma Derivatives Market: Overview
This report on bovine blood plasma derivatives market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, providing products and derivatives of bovine blood plasma such as immunoglobulin, fibrinogen, bovine serum albumin, fetal bovine serum, thrombin, transferrin, new born calf serum, and others as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global bovine blood plasma derivatives market with respect to the leading market segments based on major derivatives type segment, application, and geographies.
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on bovine blood plasma derivatives market and could influence the market in the near future. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition in the market across different geographies. The competitive scenario among different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global bovine blood plasma derivatives market.
Global Bovine Blood Plasma Derivatives Market: Segmentations
Based on derivatives type, the bovine blood plasma derivatives market has been segmented into: immunoglobulin, fibrinogen, bovine serum albumin, fetal bovine serum, thrombin, transferrin, new born calf serum, others. Each of the market segments have been extensively analyzed based on the market related factors such as widening scope of animal by-products in different application, and improving supply chain and distribution network in the various geographies. Moreover, historical year-on-year growth have been taken into consideration while estimating the market size. The market size and forecast in terms of US$ million for each segment has been provided for the period from 2015 to 2025. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Bovine Blood Plasma Derivatives Market: Regional Analysis
Geographically, Bovine blood plasma derivatives market has been into five major regions: North America, Europe, Asia Pacific, and Middle East & Africa. The market size and forecast for each of these regions has been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The report also provides with market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining the market growth and future opportunities has been provided in the market overview section. This section of the report also provides with market attractiveness analysis, Porter’s five forces analysis, value chain analysis, pricing analysis and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global bovine blood plasma derivatives market.
Global Bovine Blood Plasma Derivatives Market: Competitive Landscape
The key findings section included in the report would assist existing market players in expanding their market shares, and new companies in establishing their presence in the global bovine blood plasma derivatives market. The report also profiles key players operating in the bovine blood plasma derivatives market which are Proliant Inc., Bovogen Biologicals Pty Ltd., LAMPIRE Biological Laboratories, Inc., Rocky Mountain Biologicals Inc., Thermo Fisher Scientific, Inc., Sigma-Aldrich Co. (Merck KGaA), Kraeber & Co GmbH, Auckland BioSciences Ltd., Lake Immunogenics, Inc., etc. The global bovine blood plasma derivatives market is dominated by three global vendors that accounts for more than 76.4% share of the global bovine blood plasma derivatives market.
The global Bovine Blood Plasma Derivatives market is segmented as follows:
Global Bovine blood plasma derivatives Market, by Derivatives Type
- Serum Albumin
- Fetal Bovine Serum
- New Born Calf Serum
- Others (BGG, etc.)
Global Bovine blood plasma derivatives Market, by Application
- Pharmaceutical Industry
- Diagnostics Industry
- Cell Culture/ Biotechnology
- Research and Development
- Food Industry
- Cosmetic Industry
- Others (Nutrition Supplements, etc.)
Global Bovine blood plasma derivatives Market, by Geography
- North America
- Rest of the Europe
- New Zealand
- Rest of Asia
- Latin America (LATAM)
- Rest of LATAM
- Middle East & Africa
- GCC Countries
- South Africa
- Rest of MEA